United Therapeutics Corporation (UTHR)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$25.07B
EV to revenue ratio (TTM)
6.80
EV to ebitda
13.42
Financial Performance
Revenue (TTM)
$3.19B
Gross profit (TTM)
$2.75B
EBITDA
$1.35B
Profitability
Operating margin (TTM)
29.00%
Profit margin
38.60%
Return on assets (TTM)
10.90%
Return on equity (TTM)
19.10%
Per Share Metrics
Revenue per share (TTM)
$74.08
EPS
$26.49
Diluted EPS (TTM)
$26.49
Book value
$148.08
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
22.22
Trailing P/E
22.22
Forward P/E
18.45
PEG ratio
2.22
Price to sales ratio (TTM)
7.86
Price to book ratio (TTM)
3.95
Growth
Quarterly earnings growth (YoY)
4.10%
Quarterly revenue growth (YoY)
-20.30%
Analyst Sentiment
Strong buy
3
Buy
8
Hold
3
Sell
1
Strong sell
0
Risk & Volatility
Beta
0.48